Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
$25.00v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Showing all 3 results
v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
v2i1: pp. 1-16 Jerome S Osteryoung; Kirk Brown; Mark Henniger; Business Valuation and Lost Profits 1992
Lauren Guest, David Schap, and Thi Tran. 2015. The ‘‘Loss of Chance’’ Rule as a Special Category of Damages in Medical Malpractice: A State-by-State Analysis. Journal of Legal Economics 21(2): pp. 53–107
Subtotal: $75.00